| Dapagliflozin | Glibenclamide | p |
---|---|---|---|
Posttreatment change in the Rest FMD at 1 min, % | 3.3 (8.2) | − 1.2 (7.5) | 0.0001 |
Posttreatment change in the Post I/R FMD at 1 min, % | 2.1 (9.4) | − 0.4 (11.1) | 0.264 |
Posttreatment change in the AUC of arterial diameter during the 5-min course of Rest FMD, mm | 0.5 ± 3.5 | − 0.3 ± 3.5 | 0.001 |
Posttreatment change in the peak of systolic velocity, cm/sec | Â | Â | Â |
 At baseline | 3.6 (39.9) | − 0.41 (29.8) | 0.0001 |
 At 1-min | 6.7 (49.5) | − 2.3 (49.1) | 0.0001 |
 At 5-min | 6.3 (32.3) | − 2.6 (47.0) | 0.0001 |
Posttreatment change in the end diastolic velocity, cm/sec | Â | Â | Â |
 At baseline | − 0.13 (4.01) | − 0.12 (4.52) | 0.387 |
 At 1-min | − 0.02 (8.89) | − 1.15 (8.42) | 0.001 |
 At 5-min | 0.77 (3.85) | − 0.51 (3.58) | 0.0001 |
Posttreatment change in the resistive index | Â | Â | Â |
 At baseline | 0.009 (0.06) | 0.006 (0.07) | 0.135 |
 At 1-min | − 0.01 (0.12) | 0.01 (0.10) | 0.0001 |
 At 5-min | − 0.02 (0.07) | 0.01 (0.07) | 0.0001 |
Posttreatment change in Nitrate levels during FMD, nmol/L | Â | Â | Â |
 At baseline | 3.2 (16) | 2.1 (10) | 0.26 |
 At 1-min | 3.3 (17) | 0.9 (18) | 0.14 |
 At 5-min | 1.2 (10) | 0.1 (14) | 0.20 |
 AUC during the 5-min course | 5.6 (25) | 2.2 (29) | 0.15 |
Posttreatment change in Nitrite levels during FMD, nmol/L | Â | Â | Â |
 At baseline | 0.013 (0.10) | 0.019 (0.11) | 0.135 |
 At 1-min | 0.031 (0.18) | 0.009 (0.10) | 0.0001 |
 At 5-min | 0.006 (0.07) | 0.0013 (0.07) | 0.0001 |
 AUC during the 5-min course | 0.18 (0.24) | 0.01 (0.15) | 0.0001 |